Executive Bio
Mr. Andrew R. Robbins, also known as Andy, has been the Chief Operating Officer of Array BioPharma, Inc., since March 2015 and served as its Senior Vice President of Commercial Operations since July 23, 2012 until March 02, 2015. In this role, Mr. Robbins is responsible for working with Array's research and development teams to refine its strategy, prioritizing portfolio investments and supporting corporate collaborations with Array's strategic partners. As Array's products move closer to market, he develops launch plans and build an integrated sales and marketing team. He has extensive commercial, development and strategic leadership expertise from a 15-year career in the pharmaceutical industry, with a specific focus on oncology/hematology products. At Hospira, Inc., he served as General Manager/Vice President of the U.S. Alternate Site business unit, focused on the sales of pharmaceuticals and medical devices to outpatient oncology, surgery, pain and dialysis customers. In this role, he led a team of approximately 100 employees, including a national sales force, to deliver over $400 million in annual revenue. Mr. Robbins served as Vice President of Corporate Development and was responsible for global branded pharmaceutical marketing and business development, research and development portfolio prioritization, global strategy and corporate venture investing. During his tenure, he designed and executed a strategy to build a late-stage hematology/oncology and acute pain pipeline via licensing and acquisition. He served on the Board of Directors for three venture-backed healthcare companies, two of which were focused on innovative hematology/oncology products. He was a commercial leader within Pfizer's oncology unit, responsible for shepherding a portfolio of 12 preclinical and clinical stage products through development using a fast-to-patient approach. Mr. Robbins holds an MBA from the Kellogg School of Management, Northwestern University and a bachelor's degree from Swarthmore College.